The adaptability of red blood cells

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Pretorius, Etheresia ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Diabetes; Glucose; Hemochromatosis; Iron; Red blood cells; Scanning electron microscopy

Indexed keywords

GLUCOSE; IRON; THROMBIN; FERRIC ION; HEMOSTATIC AGENT;

ARTICLE; CELL SHAPE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; SCANNING ELECTRON MICROSCOPE; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; URINE;

CASE-CONTROL STUDIES; DIABETES MELLITUS; ERYTHROCYTES; FERRIC COMPOUNDS; GLUCOSE; HEMOCHROMATOSIS; HEMOSTATICS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; THROMBIN;

EID: 84875950799     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-63     Document Type: Article

References (25)

1. de Almeida JP L, Oliveira S, Saldanha C. Erythrocyte as a biological sensor. Clin Hemorheol Microcirc 2012, 51:1-20.
2. Stefanowicz FA, Talwar D, O'Reilly DS, Dickinson N, Atkinson J, Hursthouse AS, Rankin J, Duncan A. Erythrocyte selenium concentration as a marker of selenium status. Clin Nutr (Edinburgh, Scotland) 2013,
3. Girasole M, Pompeo G, Cricenti A, Congiu-Castellano A, Andreola F, Serafino A, Frazer BH, Boumis G, Amiconi G. Roughness of the plasma membrane as an independent morphological parameter to study RBCs: a quantitative atomic force microscopy investigation. Biochim Biophys Acta 2007, 1768:1268-1276. 10.1016/j.bbamem.2007.01.014, 17320813.
4. Antonio PD, Lasalvia M, Perna G, Capozzi V. Scale-independent roughness value of cell membranes studied by means of AFM technique. Biochim Biophys Acta 1818, 2012:3141-3148.
5. Buys AV, Van Rooy MJ, Soma P, Van Papendorp D, Lipinski B, Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol 2013, 12:25. 10.1186/1475-2840-12-25, 3599682, 23356738.
6. Girasole M, Dinarelli S, Boumis G. Structure and function in native and pathological erythrocytes: a quantitative view from the nanoscale. Micron (Oxford, England: 1993) 2012, 43:1273-1286.
7. Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2012, 50:635-641.
8. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Aspects Med 2001, 22:1-87. 10.1016/S0098-2997(00)00006-6, 11207374.
9. Lipinski B. Hydroxyl radical and its scavengers in health and disease. Oxidative Med Cell Longevity 2011, 2011:809696.
10. Pretorius E, Lipinski B. Iron alters red blood cell morphology. Blood 2013, 121:9. 10.1182/blood-2012-09-454793, 23409279.
11. Utzschneider KM, Kowdley KV. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 2010, 6:26-33. 10.1038/nrendo.2009.241, 20010968.
12. Cheung CL, Cheung TT, Lam KS, Cheung BM. High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults. Clin Nutr (Edinburgh, Scotland) 2012,
13. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications 2001, 15:203-210. 10.1016/S1056-8727(01)00143-X, 11457673.
14. Goot K, Hazeldine S, Bentley P, Olynyk J, Crawford D. Elevated serum ferritin - what should GPs know?. Aust Fam Physician 2012, 41:945-949.
15. Rong Y, Bao W, Rong S, Fang M, Wang D, Yao P, Hu FB, Liu L. Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis. Am J Epidemiol 2012, 176:461-472. 10.1093/aje/kws126, 22908207.
16. de Luan C, Li H, Li SJ, Zhao Z, Li X, Liu ZM. Body iron stores and dietary iron intake in relation to diabetes in adults in North China. Diabetes Care 2008, 31:285-286.
17. Pretorius E, Lipinski B. Thromboembolic ischemic stroke changes red blood cell morphology. Cardiovasc Pathol 2013, pii: S1054-8807(12)00151-2.
18. Pretorius E, Bester J, Vermeulen N, Lipinski B. Oxidation Inhibits Iron-induced Blood Coagulation. Curr Drug Targets 2013, 14(1):13-9. 10.2174/138945013804806541, 3580830, 23170793.
19. Pretorius E, Vermeulen N, Bester J, Lipinski B, Kell DB. A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy. Toxicol Mech Methods 2013, [Epub ahead of print].
20. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994, 107:453-459.
21. Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol 2009, 146:569-572. 10.1111/j.1365-2141.2009.07810.x, 19604239.
22. Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol 2009, 84:29-33. 10.1002/ajh.21317, 19006228.
23. Lipinski B, Pretorius E. Novel pathway of ironinduced blood coagulation: implications for diabetes mellitus and its complications. Polskie Archiwum Medycyny Wewnetrznej 2012, 122:115-122.
24. Lynch S, Soslau G. Iron levels found in hemochromatosis patients inhibit gamma-thrombin-induced platelet aggregation. Platelets 2012, 23:611-616. 10.3109/09537104.2011.634933, 22111666.
25. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 2004, 36:2137-2143. 10.1016/j.biocel.2004.02.007, 15313461.